433 related articles for article (PubMed ID: 27067330)
1. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.
Hagihara M; Housman ST; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2014; 58(2):874-9. PubMed ID: 24277022
[TBL] [Abstract][Full Text] [Related]
3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
[TBL] [Abstract][Full Text] [Related]
5. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
6. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.
Diep JK; Sharma R; Ellis-Grosse EJ; Abboud CS; Rao GG
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203494
[TBL] [Abstract][Full Text] [Related]
8.
Chen H; Li H; Liu Z; Li J
Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
[TBL] [Abstract][Full Text] [Related]
10. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
12. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
13. High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
Lenhard JR; Bulitta JB; Connell TD; King-Lyons N; Landersdorfer CB; Cheah SE; Thamlikitkul V; Shin BS; Rao G; Holden PN; Walsh TJ; Forrest A; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 Jan; 72(1):153-165. PubMed ID: 27634916
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.
Lenhard JR; Smith NM; Bulman ZP; Tao X; Thamlikitkul V; Shin BS; Nation RL; Li J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052852
[No Abstract] [Full Text] [Related]
15. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combinations of polymyxins.
Lenhard JR; Nation RL; Tsuji BT
Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
19. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]